Charting the Translational Pathway: ISSCR Best Practices for the Development of PSC-Derived Therapies (IMAGE)
Caption
The Best Practices document emphasizes a risk-based, end-to-end development strategy – starting with informed choices about PSC starting material and scaling through manufacturing, quality control, and regulatory engagement. Presented in an intuitive, visual, and interactive format, it is designed to support informed decision-making at every stage of development and will be updated regularly to reflect the rapidly evolving scientific and regulatory environment.
Credit
ISSCR
Usage Restrictions
Credit must be given to the creator. Adaptations must be shared under the same terms.
License
CC BY-SA